Related references
Note: Only part of the references are listed.HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells
Rekha Rao et al.
BLOOD (2008)
Development and application of Hsp90 inhibitors
David B. Solit et al.
DRUG DISCOVERY TODAY (2008)
The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors
Tzu-Yin Lin et al.
EXPERIMENTAL HEMATOLOGY (2008)
TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels
Mohammad Shahidul Makki et al.
NUCLEIC ACIDS RESEARCH (2008)
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines
S. Galimberti et al.
LEUKEMIA (2008)
The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis
N. Hosen et al.
LEUKEMIA (2007)
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
David B. Solit et al.
CLINICAL CANCER RESEARCH (2007)
The many facets of the Wilms' tumour gene, WT1
Peter Hohenstein et al.
HUMAN MOLECULAR GENETICS (2006)
N-terminally truncated WT1 protein with oncogenic properties overexpressed in leukemia
Anwar Hossain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structure of an Hsp90-Cdc37-Cdk4 complex
Cara K. Vaughan et al.
MOLECULAR CELL (2006)
Antileukemic activity of shepherdin and molecular diversity of Hsp90 inhibitors
Boglarka Gyurkocza et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Antiapoptotic function of 17AA(+) WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway
K. Ito et al.
ONCOGENE (2006)
AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.
S Nishida et al.
BLOOD (2006)
Estrogen receptor-α binds p53 tumor suppressor protein directly and represses its function
WS Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia
H Lapillonne et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors
OM Grbovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia
X Thomas et al.
LEUKEMIA RESEARCH (2005)
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors
P Bali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG) on pediatric acute lymphoblastic leukemia (ALL) with respect to Bcr-Abl status and imatinib mesylate sensitivity
LM Hawkins et al.
PEDIATRIC RESEARCH (2005)
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
Y Oka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Transcriptional activation of c-myc proto-oncogene by WT1 protein
YQ Han et al.
ONCOGENE (2004)
WT1 gene expression:: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients -: results from a single-centre study
M Ostergaard et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Therapeutic and diagnostic implications of Hsp90 activation
A Kamal et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Regulation of survivin function by Hsp90
P Fortugno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia
M Garg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
A Kamal et al.
NATURE (2003)
WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies
C Rosenfeld et al.
LEUKEMIA (2003)
Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System score in patients with myelodysplastic syndromes
D Cilloni et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The coexpression of the apoptosis-related genes bcl-2 and wt1 in predicting survival in adult acute myeloid leukemia
T Karakas et al.
LEUKEMIA (2002)
Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein
JH Laity et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
